Author

S. Davuluri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

A. K. Bajpai· 2 shared K. K. Acharya· 2 shared A. D. Robinson· 1 shared A. Kolodkin· 1 shared A. S. Guru· 1 shared B. V. S. K. Chakravarthi· 1 shared C. D. Willey· 1 shared D. K. Crossman· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. K. Bajpai

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Tumor- and Nerve-Derived Axon Guidance Molecule Promotes Pancreatic Ductal Adenocarcinoma Progression and Metastasis through Macrophage Reprogramming

N. Thielman, V. Funes, S. Davuluri, H. lbanez, W.-C. Sun, J. Fu, K. Li, S. Muth, X. Pan, K. Fujiwara, D. Thomas, M. Henderson, S. S. Teh, Q. Zhu, E. Thompson, , L. Zheng

This study identifies SEMA3D as a dual driver of pancreatic ductal adenocarcinoma progression and metastasis through tumor- and nerve-derived mechanisms involving macrophage reprogramming.

bioRxiv · Oct 24, 2023 · PreprintCancer Biology

Integrated transcriptomic meta-analysis provides novel insights into breast cancer molecular subtypes

A. K. Bajpai, S. Davuluri, K. Thirumurugan, K. K. Acharya

This study performs a meta-analysis of transcriptomic data to identify subtype-specific candidate genes in breast cancer and suggests potential therapeutic targets.

bioRxiv · Aug 4, 2021 · PreprintCancer Biology

Therapeutically actionable PAK4 is amplified, overexpressed and involved in bladder cancer progression

D. S. Chandrashekar, B. V. S. K. Chakravarthi, A. D. Robinson, J. C. Anderson, S. Agarwal, S. A. Hodigere Balasubramanya, M.-L. Eich, A. K. Bajpai, S. Davuluri, M. S. Guru, A. S. Guru, G. Naik, D. L. Della Manna, K. K. Acharya, S. Carskadon, , S. Varambally

This study identifies PAK4 amplification and overexpression in bladder cancer and shows PAK4 inhibition reduces tumor growth, with potential for combination therapy.

bioRxiv · Aug 20, 2019Cancer Biology